Literature DB >> 24173191

Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases.

Mariana Gontijo Ramos1, Daniel Gontijo Ramos, Gabriel Gontijo, Camila Gontijo Ramos, Tania Nely Rocha, Rafael Henrique Rocha.   

Abstract

There are many alternatives to treat vitiligo, including surgical procedures, which are recommended for patients resistant to other therapies. The melanocyte/keratinocyte transplantation consists in the separation of epidermal cells obtained from a donor site and spreading these cells on the depigmented and dermabraded recipient area. Two patients were submitted to transplantation, showing more than 70% repigmentation in the treated areas after four months, both with excellent degree of satisfaction. The method requires some laboratory skills, but represents a simple and safe procedure.

Entities:  

Mesh:

Year:  2013        PMID: 24173191      PMCID: PMC3798362          DOI: 10.1590/abd1806-4841.20132054

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.

Authors:  Sanjeev V Mulekar
Journal:  Int J Dermatol       Date:  2005-10       Impact factor: 2.736

2.  Melanocyte transplant in piebaldism: case report.

Authors:  Daniela Rezende Neves; José Rogério Régis Júnior; Patrícia Jannuzzi Vieira e Oliveira; Renata Indelicato Zac; Kleber de Sousa Silveira
Journal:  An Bras Dermatol       Date:  2010 May-Jun       Impact factor: 1.896

3.  Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option.

Authors:  Imran Majid; Saher Imran
Journal:  Indian J Dermatol Venereol Leprol       Date:  2012 Mar-Apr       Impact factor: 2.545

4.  Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.

Authors:  Richard H Huggins; Marsha D Henderson; Sanjeev V Mulekar; David M Ozog; Holly A Kerr; Gordon Jabobsen; Henry W Lim; Iltefat H Hamzavi
Journal:  J Am Acad Dermatol       Date:  2011-08-23       Impact factor: 11.527

5.  Vitiligo epidemiological profile and the association with thyroid disease.

Authors:  Daniel Holthausen Nunes; Ligia Maria Hademann Esser
Journal:  An Bras Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.896

6.  Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA.

Authors:  Carlos D'Aparecida dos Santos Machado Filho; Fernando Augusto Almeida; Rodrigo Sestito Proto; Gilles Landman
Journal:  Sao Paulo Med J       Date:  2005-07-07       Impact factor: 1.044

7.  Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation.

Authors:  A Rao; S Gupta; A K Dinda; A Sharma; V K Sharma; G Kumar; D K Mitra; C K Prashant; G Singh
Journal:  Br J Dermatol       Date:  2012-06       Impact factor: 9.302

Review 8.  Dermatosurgical techniques for repigmentation of vitiligo.

Authors:  Marsia Rusfianti; Yohanes Widodo Wirohadidjodjo
Journal:  Int J Dermatol       Date:  2006-04       Impact factor: 2.736

9.  Leucoderma treated by transplantation of a basal cell layer enriched suspension.

Authors:  M J Olsson; L Juhlin
Journal:  Br J Dermatol       Date:  1998-04       Impact factor: 9.302

10.  Autologous Non-cultured Basal Cell-Enriched Epidermal Cell Suspension Transplantation in Vitiligo: Indian Experience.

Authors:  Munish Paul
Journal:  J Cutan Aesthet Surg       Date:  2011-01
  10 in total
  3 in total

1.  Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.

Authors:  Mariana Gontijo Ramos; Daniel Gontijo Ramos; Camila Gontijo Ramos
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 2.  Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies.

Authors:  Ana Cláudia Guimarães Abreu; Gabriela Guy Duarte; Juliana Yasmin Pains Miranda; Daniel Gontijo Ramos; Camila Gontijo Ramos; Mariana Gontijo Ramos
Journal:  Autoimmune Dis       Date:  2015-09-17

3.  Simplified Non-cultured Non-trypsinised Epidermal Cell Graft Technique Followed by Psoralen and Ultraviolet A Light Therapy for Stable Vitiligo.

Authors:  Dilip Kachhawa; Pankaj Rao; Gyaneshwar Kalla
Journal:  J Cutan Aesthet Surg       Date:  2017 Apr-Jun
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.